Synthesis and evaluation of novel bioactive composite starch/bioactive glass microparticles
The aim of the development of composite materials is to combine the most desired properties of two or more materials. In this work, the biodegradable character, good controlled‐release properties, and natural origin of starch‐based biomaterials are combined with the bioactive and bone‐bonding proper...
Gespeichert in:
Veröffentlicht in: | Journal of biomedical materials research 2004-09, Vol.70A (3), p.442-449 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The aim of the development of composite materials is to combine the most desired properties of two or more materials. In this work, the biodegradable character, good controlled‐release properties, and natural origin of starch‐based biomaterials are combined with the bioactive and bone‐bonding properties of bioactive glass (BG). Novel, bioactive composite starch–BG microparticles were synthesized starting from a blend of starch and polylactic acid (50%/50% wt) with BG 45S5 powder using a simple emulsion method. Morphological and chemical characterization showed that these particles exhibited a spherical morphology with sizes up to 350 μm and that BG 45S5 was incorporated successfully into the composite particles. Upon immersion in a solution simulating body fluids, for periods up to 3 weeks, their bioactive nature was confirmed, as a calcium‐phosphate layer resembling biological apatite was formed onto their surface. The short‐term cytotoxicity of these materials was also tested by placing 24‐h leachables of the materials extracted in culture medium in contact with a fibroblastic cell line (L929) up to 72 h. At this time period, two biochemical tests—MTT and total protein quantification—were performed. The results showed that these materials are not cytotoxic. These results constitute the basis of future encapsulation studies using bone‐acting therapeutic agents such as bone morphogenetic proteins or other bone‐relevant factors. The particles developed here may be very useful for applications in which controlled release, degradability, and bone‐bonding ability are the main requirements. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res 70A: 442–449, 2004 |
---|---|
ISSN: | 1549-3296 0021-9304 1552-4965 1097-4636 |
DOI: | 10.1002/jbm.a.30099 |